Merck & Co., Inc. Operating Lease, Liability, Noncurrent
Merck & Co., Inc. (MRK) had Operating Lease, Liability, Noncurrent of $901.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-02-24
- 2025-12-31: Operating Lease, Liability, Noncurrent $901.00M.
- 2024-12-31: Operating Lease, Liability, Noncurrent $877.00M.
- 2023-12-31: Operating Lease, Liability, Noncurrent $928.00M.
- 2022-12-31: Operating Lease, Liability, Noncurrent $1.01B.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $901.00M 10-K · filed 2026-02-24 | |
| 2024-12-31 | $877.00M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $928.00M 10-K · filed 2025-02-25 | |
| 2022-12-31 | $1.01B 10-K · filed 2024-02-26 | |
| 2021-12-31 | $1.23B 10-K · filed 2023-02-24 | |
| 2020-12-31 | $1.33B 10-K · filed 2022-02-25 | $1.36B 10-K · filed 2021-02-25 |
| 2019-12-31 | $768.00M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $779.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $752.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $777.00M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |